X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5) 5
life sciences (5) 5
alzheimer's disease (4) 4
tau protein (4) 4
analysis (3) 3
cerebrospinal fluid (3) 3
diagnosis (3) 3
enzyme-linked immunosorbent assay (3) 3
medical research (3) 3
medicine, experimental (3) 3
neurodegenerative diseases (3) 3
[sdv]life sciences [q-bio] (2) 2
age (2) 2
alzheimer’s disease (2) 2
biomarkers (2) 2
cerebrospinal-fluid (2) 2
clinical neurology (2) 2
dementia (2) 2
pathology (2) 2
research (2) 2
sclérose en plaques (2) 2
[ sdv ] life sciences [q-bio] (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
abeta pathology (1) 1
adult (1) 1
adults (1) 1
alzheimer brain (1) 1
alzheimer disease - blood (1) 1
alzheimer disease - cerebrospinal fluid (1) 1
alzheimer disease - diagnosis (1) 1
alzheimer disease - epidemiology (1) 1
alzheimers disease (1) 1
amyloid (1) 1
amyloid beta-peptides - blood (1) 1
amyloid beta-peptides - cerebrospinal fluid (1) 1
amyloid-beta (1) 1
association (1) 1
biological markers (1) 1
biomarker (1) 1
biomarqueurs (1) 1
blood (1) 1
brain (1) 1
brain metastases (1) 1
brain tumors (1) 1
breast cancer (1) 1
cancer (1) 1
cancer patients (1) 1
care and treatment (1) 1
clinical mass spectrometry (1) 1
clinical medicine (1) 1
clinical trials (1) 1
cognitive ability (1) 1
comorbidity (1) 1
contaminants (1) 1
creutzfeldt-jakob disease (1) 1
creutzfeldt–jakob disease (1) 1
cross-sectional studies (1) 1
dementia disorders (1) 1
deposits (1) 1
development and progression (1) 1
diagnostic imaging (1) 1
digestion (1) 1
disease (1) 1
down syndrome (1) 1
down syndrome - blood (1) 1
down syndrome - cerebrospinal fluid (1) 1
down syndrome - epidemiology (1) 1
down's syndrome (1) 1
female (1) 1
genetic aspects (1) 1
gfap (1) 1
growth hormone (1) 1
growth hormones (1) 1
guidelines (1) 1
handicapped accessibility (1) 1
human health and pathology (1) 1
humans (1) 1
in-vitro diagnostics (1) 1
intellectual disabilities (1) 1
lc-ms (1) 1
lc-ms/ms (1) 1
lc–ms (1) 1
lesions (1) 1
male (1) 1
medical diagnosis (1) 1
medical errors (1) 1
medical examination (1) 1
medical laboratory technology (1) 1
medicine & public health (1) 1
memory (1) 1
metastasis (1) 1
method validation (1) 1
middle aged (1) 1
nad (1) 1
neoplasms. tumors. oncology. including cancer and carcinogens (1) 1
neurodegeneration (1) 1
neurofilament light-chain (1) 1
neurofilament proteins - blood (1) 1
neurofilament proteins - cerebrospinal fluid (1) 1
neurofilaments chaines légères (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Neurology, ISSN 1474-4422, 10/2018, Volume 17, Issue 10, pp. 860 - 869
Diagnosis of Alzheimer's disease in Down syndrome is challenging because of the absence of validated diagnostic biomarkers. We investigated the diagnostic... 
DEMENTIA | AMYLOID-BETA | NEUROFILAMENT LIGHT-CHAIN | NEURODEGENERATION | TAU | INTELLECTUAL DISABILITIES | ASSOCIATION | CLINICAL NEUROLOGY | Cross-Sectional Studies | Comorbidity | Humans | Middle Aged | Down Syndrome - epidemiology | Male | tau Proteins - cerebrospinal fluid | Prodromal Symptoms | Alzheimer Disease - cerebrospinal fluid | Amyloid beta-Peptides - blood | tau Proteins - blood | Alzheimer Disease - diagnosis | Neurofilament Proteins - cerebrospinal fluid | Down Syndrome - cerebrospinal fluid | Neurofilament Proteins - blood | Down Syndrome - blood | Amyloid beta-Peptides - cerebrospinal fluid | Adult | Alzheimer Disease - epidemiology | Female | Alzheimer Disease - blood | Medical research | Medical examination | Analysis | Medicine, Experimental | Adults | Diagnostic imaging | Diagnosis | Down syndrome | Biological markers | Alzheimer's disease | Blood | Neuroimaging | Plasma | Intellectual disabilities | Clinical trials | Thyroid gland | Cerebrospinal fluid | Medical diagnosis | Psychotropic drugs | Proteins | Down's syndrome | Neurodegeneration | Dementia disorders | Amyloid | Age | Enzyme-linked immunosorbent assay | Handicapped accessibility | Neurodegenerative diseases | Studies | Tau protein | Biomarkers | Alzheimers disease | Dementia | Life Sciences | Human health and pathology | Neurons and Cognition
Journal Article
Journal Article
Critical Reviews in Clinical Laboratory Sciences, ISSN 1040-8363, 07/2018, Volume 55, Issue 5, pp. 346 - 358
Clinical mass spectrometry proteomics (cMSP) assays are being increasingly used in clinical laboratories for analyzing peptides and proteins. It has therefore... 
method validation | Clinical mass spectrometry | guidelines | LC-MS | LC–MS | BIOMARKER | QUANTIFICATION | QUANTITATION | CEREBROSPINAL-FLUID | PREDICTION | LC-MS/MS | DIGESTION | PLASMA-PROTEINS | MEDICAL LABORATORY TECHNOLOGY | PEPTIDASE ACTIVITY | IN-VITRO DIAGNOSTICS | Life Sciences
Journal Article
European journal of neurology, ISSN 1351-5101, 08/2019
The prognostic value of serum neurofilament light chain (sNfL), a biomarker of neurodegeneration, compared to other prognostic factors of amyotrophic lateral... 
Journal Article
Frontiers in aging neuroscience, ISSN 1663-4365, 2018, Volume 10, p. 138
Cerebrospinal fluid (CSF) biomarkers (Aβ peptides and tau proteins) improved the diagnosis of Alzheimer's disease (AD) in research and clinical settings. We... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.